Advertisement
Screener

IRONWOOD PHARMACEUTICALS, INC. (IRWD) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

2.1 / 5 stars · 41/100 Roast Me

IRONWOOD PHARMACEUTICALS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 2.93 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06

  • IRONWOOD PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 2.93M shares, a 69.39% decline year-over-year.
  • IRONWOOD PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 4.13M shares, a 83.95% decline year-over-year.
  • IRONWOOD PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 8.85M shares, a 64.50% decline year-over-year.
  • IRONWOOD PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 9.58M shares, a 61.98% decline year-over-year.
  • IRONWOOD PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 21.39M shares, a 8.54% decline from fiscal 2024.
  • IRONWOOD PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 23.39M shares, a 208.22% increase from fiscal 2023.
  • IRONWOOD PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 7.59M shares, a 51.56% decline from fiscal 2022.
  • IRONWOOD PHARMACEUTICALS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 15.66M shares, a 71.22% decline from fiscal 2021.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed
2026-06-302.93M shares
10-Q · filed 2026-08-06		3.55M shares
10-Q · filed 2026-08-06
2026-03-314.13M shares
10-Q · filed 2026-05-07
2025-12-3121.39M shares
10-K · filed 2026-02-26
2025-09-308.85M shares
10-Q · filed 2025-11-10		9.43M shares
10-Q · filed 2025-11-10
2025-06-309.58M shares
10-Q · filed 2026-08-06		26.95M shares
10-Q · filed 2026-08-06
2025-03-3125.74M shares
10-Q · filed 2026-05-07
2024-12-3123.39M shares
10-K · filed 2026-02-26
2024-09-3024.94M shares
10-Q · filed 2025-11-10		21.90M shares
10-Q · filed 2025-11-10
2024-06-3025.21M shares
10-Q · filed 2025-08-11		20.36M shares
10-Q · filed 2025-08-11
2024-03-3118.87M shares
10-Q · filed 2025-05-12		3.93M shares
10-Q · filed 2024-05-09
2023-12-317.59M shares
10-K · filed 2025-03-31
2023-09-306.59M shares
10-Q · filed 2024-11-07		9.47M shares
10-Q · filed 2024-11-07
2023-06-3038.17M shares
10-Q · filed 2024-08-08		8.30M shares
10-Q · filed 2023-08-09		40.97M shares
10-Q · filed 2024-08-08		11.11M shares
10-Q · filed 2023-08-09
2023-03-3114.01M shares
10-Q · filed 2024-05-09
2022-12-3115.66M shares
10-K · filed 2025-03-31
2022-09-3014.83M shares
10-Q · filed 2023-11-09		14.97M shares
10-Q · filed 2023-11-09
2022-06-3013.98M shares
10-Q · filed 2023-08-09		15.08M shares
10-Q · filed 2023-08-09
2022-03-3116.18M shares
10-Q · filed 2023-05-04
2021-12-3154.43M shares
10-K · filed 2024-02-16
2021-09-3052.78M shares
10-Q · filed 2022-11-03		55.25M shares
10-Q · filed 2022-11-03
2021-06-3056.64M shares
10-Q · filed 2022-08-04		56.93M shares
10-Q · filed 2022-08-04
2021-03-3157.52M shares
10-Q · filed 2022-05-05
2020-12-3158.55M shares
10-K · filed 2023-02-16
2020-09-3060.72M shares
10-Q · filed 2021-11-04		66.48M shares
10-Q · filed 2021-11-04
2020-06-3062.00M shares
10-Q · filed 2021-08-05		67.10M shares
10-Q · filed 2021-08-05
2020-03-3167.93M shares
10-Q · filed 2021-05-06
2019-12-3167.09M shares
10-K · filed 2022-02-18
2019-09-3067.48M shares
10-Q · filed 2020-11-05
2019-06-3068.58M shares
10-Q · filed 2020-08-06
2019-03-3168.38M shares
10-Q · filed 2020-05-06
2018-12-3164.08M shares
10-K · filed 2021-02-17
2018-09-3064.75M shares
10-Q · filed 2019-10-31
2018-06-3065.89M shares
10-Q · filed 2019-07-30
2018-03-3166.87M shares
10-Q · filed 2019-05-02		66.73M shares
10-Q · filed 2018-05-04
2017-12-3163.92M shares
10-K · filed 2020-02-13
2017-09-3064.19M shares
10-Q · filed 2018-11-06		64.12M shares
10-Q · filed 2017-11-02
2017-06-3064.52M shares
10-Q · filed 2018-08-06
2017-03-3165.08M shares
10-Q · filed 2018-05-04
2016-12-3162.65M shares
10-K · filed 2019-02-25
2016-09-3063.46M shares
10-Q · filed 2017-11-02
2016-06-3064.01M shares
10-Q · filed 2017-08-03
2016-03-3164.33M shares
10-Q · filed 2017-05-08
2015-12-3162.04M shares
10-K · filed 2018-02-22
2015-09-3062.08M shares
10-Q · filed 2016-11-07
2015-06-3062.29M shares
10-Q · filed 2016-08-08
2015-03-3121.63M shares
10-Q · filed 2016-05-10
2014-12-3120.06M shares
10-K · filed 2017-02-22
2014-09-3020.88M shares
10-Q · filed 2015-11-05
2014-06-3021.02M shares
10-Q · filed 2015-08-07
2014-03-3121.92M shares
10-Q · filed 2015-05-06
2013-12-3120.93M shares
10-K · filed 2016-02-19
2013-09-3020.30M shares
10-Q · filed 2013-10-28		20.30M shares
10-Q · filed 2014-11-05		20.30M shares
10-Q · filed 2013-10-28
2013-06-3020.52M shares
10-Q · filed 2014-08-05		20.52M shares
10-Q · filed 2013-08-08
2013-03-3120.91M shares
10-Q · filed 2014-04-29		20.91M shares
10-Q · filed 2013-04-23
2012-12-3119.62M shares
10-K · filed 2015-02-18		19.62M shares
10-K · filed 2013-02-21
2012-09-309.04M shares
10-Q · filed 2013-10-28		18.92M shares
10-Q · filed 2013-10-28
2012-06-3018.81M shares
10-Q · filed 2013-08-08
2012-03-3118.77M shares
10-Q · filed 2013-04-23
2011-12-3116.59M shares
10-K · filed 2014-02-07		16.58M shares
10-K · filed 2012-02-29
2011-09-3016.04M shares
10-Q · filed 2012-11-06		16.04M shares
10-Q · filed 2012-11-06
2011-06-3015.99M shares
10-Q · filed 2012-08-07
2011-03-3116.29M shares
10-Q · filed 2012-05-10
2010-12-3114.89M shares
10-K · filed 2013-02-21
2009-12-3184.03M shares
10-K · filed 2012-02-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nuvectis Pharma, Inc. (NVCT)United States$0.705B-17.53
Climb Bio, Inc. (CLYM)United States$0.683B-13.03
Verastem, Inc. (VSTM)United States$0.706B-1.71
ZEVRA THERAPEUTICS, INC. (ZVRA)United States$0.668B14.61
COLLEGIUM PHARMACEUTICAL, INC (COLL)United States$0.737B24.57
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
Faeth Therapeutics, Inc. (FTH)United States$0.750B
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
Neurogene Inc. (NGNE)$0.625B-4.46
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78
Advertisement